{
    "code": "02021344",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021344",
    "time": "2021-10-29 08:33:27",
    "許可證字號": "衛署藥輸字第021344號",
    "註銷狀態": "已註銷",
    "註銷日期": "109\/02\/21",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "110\/08\/27",
    "發證日期": "85\/08\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202134403",
    "中文品名": "冠達悅喜樂錠３０毫克",
    "英文品名": "ADALAT CC 30MG",
    "適應症": "高血壓",
    "劑型": "121持續性藥效錠",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NIFEDIPINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1426201100  台灣拜耳股份有限公司",
    "申請商地址": "台北市信義區信義路五段7號台北101大樓之53至54樓",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412400900",
            "成分名稱": "NIFEDIPINE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2412400900",
            "成分名稱": "NIFEDIPINE",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "ADALAT CC 30mg_021344_tablets-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021344&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Adalat_CC 30mg 仿單-107-11-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021344&Seq=013&Type=9"
        },
        {
            "title": "20170614_Adalat CC 30mg_印妥仿單電子檔-106-06-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021344&Seq=012&Type=9"
        },
        {
            "title": "ADALAT CC 30mg_021344_box-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021344&Seq=005&Type=8"
        }
    ]
}